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population reference and healthy 
standard blood pressure range 
charts in pregnancy: findings from 
the Born in Bradford cohort study
Gillian Santorelli  1, Debbie A. Lawlor1,2,3, Jane West  1, Derek tuffnell4 & Diane farrar  1*
Women who develop gestational hypertension are at increased risk of adverse perinatal and longer-
term outcomes. Reference charts may aid early detection of raised blood pressure (BP) and in doing 
so reduce adverse outcome risk. We used repeated BP measurements to produce ‘reference’ (whole 
population) and ‘standard’ (healthy pregnancies only) gestational-age-specific BP charts for all pregnant 
women (irrespective of ethnicity) and for White British (WB) and Pakistani (P) women. We included 9218 
women recruited to the Born in Bradford study with 74,770 BPs. 19% of the whole population, 11% and 
25% of WB and P women respectively were defined as healthy pregnancies. For reference and standard 
charts, for all women and each ethnic group, SBP/DBP at 12 and 20 weeks gestation was similar before 
rising at 37 weeks. DBP/SBP of reference charts for all women and for each ethnic group were higher 
than those of the corresponding standard charts. Compared to WB, P women had lower SBP/DBP at 12, 
20 and 37 weeks gestation. To conclude; maternal population BP reference charts are higher compared 
to standard charts (healthy pregnancies) and are influenced by ethnicity.
Substantial cardiovascular changes occur in pregnancy to facilitate normal growth and development of the pla-
centa and fetus. However, around 10% of women experience hypertensive disorders in pregnancy (HDP (gesta-
tional hypertension (GH) and pre-eclampsia (PE))1,2, and are consequently at increased risk of adverse perinatal 
outcomes, including caesarean and preterm birth, intrauterine growth restriction and maternal and fetal death3–5.
For fetal and childhood growth, there are established patterns of change. Deviation from these patterns has 
been used for decades to monitor healthy growth. Broadly two types of chart are used– standard and reference 
charts6–8. Standard charts aim to represent worldwide normal fetal and childhood growth. Generally, reference 
charts describe the growth of fetuses and children from a defined geographical area, characteristics including 
ethnicity (and for fetal growth, maternal characteristics including BMI) may also be considered. The appropriate-
ness of standard versus reference charts remains contentious; the argument against reference charts (and country 
specific charts) is that they may normalize those at highest risk because they fail to appreciate that a woman’s 
socioeconomic status is a stronger predictor of health status than her genetic code and when unconstrained 
by nutritional and socio-economic factors, fetal and infant growth is generally consistent across populations8,9. 
Standard charts therefore describe how infants should grow and reference charts describe how infants of mothers 
with specific characteristics have grown.
Similarly to fetal and childhood growth, blood pressure (BP) in pregnancy is repeatedly measured and high BP 
first identified after 20 weeks is used to determine the diagnosis of GH and PE. Women with these conditions then 
have more intensive antenatal care. We and others have previously shown that BP at the start of pregnancy and 
change across pregnancy varies by maternal characteristics including body mass index (BMI kg/m2), parity10,11, 
and ethnicity11,12, both in normal pregnancies and in those complicated by HDP. It is therefore possible that ref-
erence charts that reflect population BP change or standard BP charts that reflect BP change in uncomplicated 
pregnancies might help identify women at risk earlier in pregnancy compared to diagnostic BP thresholds.
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BP reference ranges for women with differing characteristics vary13 and the addition of BP measurements 
improves risk prediction models for PE and its associated adverse outcomes14. However, these studies were con-
ducted in a predominantly White European population and it is clear that ethnicity can influence physiology. 
Compared to White Europeans, South Asians are at increased risk of insulin resistance and cardiovascular dis-
ease15–18. In pregnancy this is reflected in a higher incidence of gestational diabetes19. We have shown that com-
pared to Pakistani (P) women, White British (WB) women start pregnancy with higher systolic blood pressure 
(SBP) and diastolic blood pressure (DBP), are less likely to develop GH, but are just as likely to develop PE11. It is 
likely that women who are diagnosed with GH/PE reach the diagnostic BP thresholds through different patterns 
of BP change (e.g. starting pregnancy, and continuing through it, with on average higher BP, having no or a less 
marked decline in BP in early pregnancy or a steeper rise after 20 weeks). Understanding how these differences 
translate into maternal BP standard and reference charts would help clarify their utility in clinical practice.
The aims of this study were to develop population reference charts (irrespective of maternal conditions, behav-
iours or characteristics) and standard charts (women defined as having a healthy pregnancy: no evidence of 
pre-existing hypertension, pre-existing diabetes or gestational diabetes, gestational hypertension or pre-eclampsia 
in the current pregnancy, no smoking or alcohol during pregnancy, a healthy BMI, did not deliver a preterm 
infant or an infant who was small for gestational age (SGA) or large for gestational age (LGA)). We stratified by 
ethnicity and parity.
Methods
participants. Born in Bradford (BiB) is a prospective longitudinal cohort study established to examine how 
genetic, nutrition, environment, behavioural and social factors impact on health and development during child-
hood; full details of the study methodology have been reported elsewhere20. At recruitment, participants gave 
informed written consent, or, if under 18, from a parent and/or legal guardian. Briefly, most women were recruited 
while attending their oral glucose tolerance test (OGTT), which is offered to all women booked for delivery at the 
Bradford Royal Infirmary at approximately 26–28 weeks gestation. Those who gave consent completed an inter-
viewer-administered baseline questionnaire. The full BiB cohort recruited 12,450 pregnant women across 13,773 
pregnancies between March 2007 and December 2010. The cohort for the present study included 10,895 women 
who had at least two BP and proteinuria measurements recorded antenatally, completed a baseline questionnaire 
and had birth outcomes recorded. As this is not an experimental study, protocol/analysis plan approval was not 
required. The following exclusions were applied: still births (n he59), multiple births (n 9)138), pregnancies result-
ing in the birth of children with congenital anomalies (n 38649), and women who had missing baseline question-
naire or birth outcome data (n 49831). The final cohort for this study is 9,218: 3,701 White British, 4,109 Pakistani 
and 1,408 women of other ethnic groups (see Fig. 1 for a flow of participants through the study).
Maternal and neonatal measurements. BP and proteinuria measurements were recorded during 
pregnancy by doctors, midwives or trained health care assistants as part of routine antenatal care. Four trained 
research assistants abstracted this information from participant’s paper records; five percent of abstractions were 
checked for accuracy and error rates were less than 1%. Information on existing hypertension and existing dia-
betes mellitus was also obtained from the pregnancy paper records; parity and birth weight were obtained from 
the electronic maternity hospital records. Maternal height and weight were measured at pregnancy booking 
which was generally before 12 weeks gestation. Gestational age at delivery was estimated from the date of delivery 
and the 10 week ultrasound scan. Gender-specific birth weight centiles were calculated using the UK90 growth 
reference21. Information on congenital anomalies was obtained from the Yorkshire and Humber Congenital 
Anomalies Register and primary care records up to five years of age22.
Definition of a healthy pregnancy. We defined a healthy pregnancy as one with no evidence of any of 
the following adverse pregnancy/perinatal outcomes and lifestyle characteristics: pre-existing hypertension 
(n = 81), pre-existing diabetes (n = 13) or developed gestational diabetes in the current pregnancy (defined using 
oral glucose tolerance results at 26–28 weeks gestation, using the glucose thresholds applied at the time of the 
study23; n = 718), developed gestational hypertension (defined using the thresholds: SBP ≥ 140 mm/Hg and/or 
DBP ≥ 90 mm/Hg on at least two occasions after 20 weeks gestation; n = 658) or pre-eclampsia (defined using 
the gestational hypertension thresholds with concurrent proteinuria of ≥1 + after 20 weeks gestation; n = 233), 
smoked (n = 1526) or consumed alcohol (n = 1859) during pregnancy, did not have a healthy BMI (defined as a 
BMI < 18.5 or ≥25 kg/m2; n = 5055), preterm delivery (defined as gestational age <37 completed weeks; n = 447), 
delivery of a SGA (defined as birthweight below the 10th centile; n = 2351) or LGA (defined as birthweight above 
the 90th centile; n = 373) infant.
Statistical analysis. Multilevel models were used to produce references ranges for SBP and DBP across ges-
tation with measurement occasion (as level 1) within women (level 2) in the whole cohort (population pregnancy 
reference BP ranges) and then separately in the subgroup of women defined as having a ‘healthy pregnancy’ 
(healthy pregnancy standard BP ranges). As a small proportion of women had many BP measurements, one 
measurement was randomly selected per two-week period to avoid them overly influencing the model. This was 
achieved by creating a random number for each record using the invnorm(uniform) command in Stata, sorting 
data by participant identifier, gestation period and random number, then choosing the first record within each 
gestation period. Models were fitted separately for SBP and DBP, with gestational age as the exposure. The shape of 
the BP trajectory across pregnancy was described by fitting restricted cubic splines using knot points which have 
been previously identified in the same dataset using linear splines (at 24, 30 and 36 weeks)11, with two additional 
outer knots at the 5th and 9th percentiles of the data (14 and 40 weeks)11. The median time of the first antenatal 
BP measurement (12 weeks) was used as the baseline gestational age and was included as a level 1 random effect.
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Reference (irrespective of health conditions, behaviors or characteristics) and standard (healthy pregnancies) 
BP range charts were derived for all women (irrespective of ethnicity) and separately for the two largest ethnic 
groups (White British (WB) and Pakistani (P) women). There were too few women of other ethnicities to conduct 
meaningful analysis. MLwiN version 2.32 was used to fit the multilevel models through Stata24. Stata version 13.1 
(Stata Corp, College Station, Texas, USA) was used for all other analyses.
Ethics approval. Ethics approval for the study was granted by Bradford National Health Service Research 
Ethics Committee (07/H1302/112), all research was performed in accordance with relevant guidelines and 
regulations.
Results
The characteristics of all women included in the sample and stratified by WB and P ethnic group are presented in 
Table 1. There were 74,770 BP measurements taken between 9 and 41 weeks gestation, with a median of 8 meas-
urements per women (IQR 7 to 9). Overall, 19% of women were defined as having a healthy pregnancy, with fewer 
WB women having healthy pregnancies compared to P women (11.5% vs 25.2%).
The reference and standard charts for SBP and DBP between 12 and 40 weeks gestation are shown for all 
women and for WB and P women in Fig. 2a,b, and by parity in Supplementary Figs. 1 and 2. The predicted mean 
SBP and DBP with 95% CIs at 12, 20 and 37 weeks are presented overall and stratified by ethnicity in Table 2 and 
further stratified by parity in Supplementary Table 1.
Reference vs standard charts. For both reference and standard charts and for all women, WB and P 
women, SBP and DBP at 12 and 20 weeks gestation was similar before rising by ~2 mm/Hg to 3 mm/Hg at 37 
weeks (see Fig. 2a,b). The DBP and SBP predicted means of the reference charts for all women (irrespective of 
ethnicity), WB and P women, were higher than those of the corresponding standard charts. The 95% CIs of each 
group’s reference charts were between 3 mm/Hg and 8 mm/Hg wider than each group’s equivalent standard chart.
Ethnic differences: reference charts. Compared to WB women, P women had lower mean SBP and DBP 
(~5 mm/Hg and ~2–3 mm/Hg respectively) at each of the three gestational ages (12, 20 and 37 weeks). For both 
ethnic groups mean SBP at 12 and 20 weeks and DBP at 12 and 20 weeks was similar before rising at 37 weeks 
gestation by ~3–4 mm/Hg (see Table 2 and Fig. 2a,b).
Figure 1. Study flow chart.
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Ethnic differences: standard charts. Similar to reference charts, the standard charts of P women had 
lower mean SBP and DBP across pregnancy compared to WB women. Within each ethnic group, mean SBP at 12 
and 20 weeks and DBP at 12 and 20 weeks, was similar before rising at 37 weeks gestation by ~3–4 mm/Hg (see 
Table 2 and Fig. 2a,b).
Parity differences: standard versus reference charts. The SBP and DBP predicted means of the stand-
ard charts for all women, WB and P women were lower than those of the corresponding reference charts. The 
upper CIs were higher and lower CIs lower for standard charts compared to the reference charts.
Parity differences: nulliparous versus multiparous charts. For both standard and reference charts, 
the predicted mean SBP for all (irrespective of ethnicity) and WB nulliparous women were generally similar to 
multiparous women at 12 weeks and 20 weeks gestation, but higher by ~2 mmHg at 37 weeks of pregnancy. The 
standard charts of P nulliparous compared to P multiparous women had slightly lower mean SBP at 12 and 20 
weeks, but higher SBP at 37 weeks. The predicted mean DBP for all and WB nulliparous women were generally 
similar to the corresponding charts of multiparous women at each time point. The reference charts of P nullipa-
rous compared to multiparous women had lower predicted mean DBP at 12 and 20 weeks and higher mean DBP 
at 37 weeks. For standard charts, P nulliparous and multiparous predicted DBP was similar at 12 and 20, at 37 
weeks however the mean DBP of nulliparous women exceeded that of multiparous women (See Sup. Table 1 and 
Sup. Fig 1 and 2).
Discussion
Using data from a large prospective birth cohort, we have produced population reference (for all pregnancies 
irrespective of maternal medical conditions, behaviours or characteristics) and standard (for normally defined 
pregnancies) BP charts and examined the influence of ethnicity and parity on these charts. We found that BP 
range varies as gestation progresses, that reference compared to standard charts have higher BP ranges across 
pregnancy and that the reference and standard charts of P compared to the corresponding charts of WB women 
are lower throughout pregnancy. The SBP ranges of charts for multiparous compared to corresponding charts of 
nulliparous women were similar, whereas the DBP ranges of charts were generally lower for multiparous com-
pared to the corresponding charts of nulliparous women.
Reference or standard BP charts for pregnant women are not currently recommended for clinical practice, 
BP thresholds are used to define high BP and in the diagnosis of HDP25–27. Placental insufficiency underlies the 
increased risk of growth restriction and preterm birth associated with HDP, however placental insufficiency may 
be present for some time prior to its identification or to the diagnosis of a HDP. It is possible that the degree of BP 
increase and pattern of BP change as well as BP level reached may contribute to the occurrence of placental insuf-
ficiency and subsequent development of adverse outcomes28,29. Therefore further research is needed to explore 
the use of BP reference and standard BP charts in the identification of deviations from usual BP change patterns, 
which may help in the earlier identification of women at increased risk of HDP associated adverse outcomes.
All (n = 9218)c White British (n = 3701) Pakistani (n = 4109)
N Median (IQR) or % N Median (IQR) or % N Median (IQR) or %
Number of measuresa 74,770 8 (7, 9) 30,826 9 (8, 10) 32,700 8 (7, 9)
Parity
Nulliparous 3004 40.0 1727 48.2 1277 32.5
Multiparous 4506 60.0 1852 51.8 2654 67.5
Pre-existing hypertension 81 0.9 45 1.2 28 0.7
Pre-existing diabetes (type 1 & 2) 13 0.1 6 0.2 6 0.2
Gestational hypertension 658 7.1 397 10.7 181 4.4
Pre-eclampsia 233 2.5 102 2.8 96 2.3
Gestational diabetes 718 7.8 170 4.6 432 10.5
Preterm delivery 447 4.9 183 4.9 187 4.6
Large for gestational age 373 4.1 232 6.3 98 2.4
Small for gestational age 2351 25.5 682 18.4 1293 31.5
Alcohol during pregnancy 1859 20.2 1640 44.3 17 0.4
Smoked during pregnancy 1526 16.6 1238 33.5 142 3.5
BMI < 18.5 or ≥25.0 5055 54.8 2099 56.7 2256 54.9
Healthy pregnancyb 1790 19.4 426 11.5 1,036 25.2
Table 1. Maternal characteristics, overall and by ethnic group. aNumber of blood pressure measurements per 
woman following random selection of one measure per two week period of pregnancy. bHealthy pregnancies are 
defined as those without medical conditions (has pre-existing hypertension, has existing diabetes or developed 
gestational diabetes, developed pre-eclampsia) and adverse pregnancy outcomes (pre-term birth, small for 
gestational age or lagre for gestational age infant) and unhealthy lifestyle characteristics (smoking and drinking 
alcohol during pregnancy, unhealthy BMI). cComposed of the following ethnic groups: White British = 3701; 
Pakistani = 4109; Other ethnicity = 1408.
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We have previously shown that the BP trajectories of P women vary from those of WB women: they are lower 
throughout the first half of pregnancy before increasing in the second half to equal the BP level of WB women11. 
Using current BP threshold criteria to define HDP27 these differences produce a lower prevalence of GH, but 
similar prevalence of PE for P compared to WB women11. We have shown that when all P pregnancies and when 
only ‘normal’ pregnancies are included, the reference ranges for P women are lower across pregnancy compared 
to WB women suggesting that deviation from the normal range will occur at a lower BP level for P compared to 
WB women. The lower BP levels of the P women’s trajectories compared to WB women, means that they would 
need greater increases in BP to achieve the current thresholds that define a HDP and these greater increases may 
contribute to a higher risk of adverse outcomes (compared to WB women).
Concerns regarding the use of BP reference (that describe population norms for all pregnancies) and standard 
(for healthy pregnancies only) charts are similar to those surrounding the use of fetal and infant growth refer-
ence charts (that describe how infants in a particular population have grown) compared to standard charts (that 
describe how unrestricted growth should occur). Reference BP charts may better describe how BP changes across 
the whole population, but these charts may underestimate risk in women most vulnerable, especially in a high 
risk population where average BP ranges may be higher than for the average (minority) ‘healthy’ (without iden-
tified risk characteristics) pregnancy. Standard BP charts that describe normal pregnancy BP ranges may over or 
under identify risk if BP change pattern deviations are not good predictors of adverse perinatal outcomes and we 
have shown that ethnicity can influence BP range levels.
Figure 2. a and b: Reference (population) and standard (healthy pregnancies) blood pressure charts for SBP and 
DBP between 12 and 40 weeks gestation for all (irrespective of ethnicity), White British and Pakistani women.
Reference charts – All pregnancies Standard charts - Healthy pregnancies
12 weeks 20 weeks 37 weeks 12 weeks 20 weeks 37 weeks
All women
SBP 108.8 (84.7, 132.9) 109.1 (85.5, 132.7) 112.5 (88.1, 136.9) 105.0 (84.2, 125.8) 104.9 (84.6, 125.3) 107.7 (86.0, 129.4)
DBP 64.7 (47.2, 82.2) 64.5 (47.7, 81.4) 68.2 (49.9, 86.4) 62.1 (46.7, 77.4) 61.8 (47.1, 76.4) 64.8 (49.2 80.5)
White British women
SBP 111.5 (87.2, 135.7) 111.7 (88.3, 135.1) 115.2 (91.1, 139.3) 107.7 (87.2, 128.2) 107.6 (88.3, 126.9) 110.6 (89.7, 131.5)
DBP 65.8 (48.0, 83.6) 65.6 (48.3, 83.0) 69.5 (51.1, 87.9) 63.1 (47.6, 78.7) 63.1 (47.8, 78.5) 66.5 (50.4, 82.6)
Pakistani women
SBP 106.7 (83.4, 129.9) 107.0 (84.1, 130.0) 110.3 (86.5, 134.2) 104.0 (83.0, 124.9) 103.8 (83.3, 124.5) 106.4 (84.8, 128.0)
DBP 63.9 (46.8, 81.0) 63.7 (47.3, 80.2) 67.1 (49.2, 85.1) 61.5 (46.0, 76.9) 61.0 (46.8, 75.3) 64.0 (48.9, 79.0)
Table 2. Mean (95% confidence intervals) systolic blood pressure and diastolic blood pressure at gestational age 
of 12, 20 and 37 weeks for standard and reference charts, stratified by ethnicity.
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Data availability
The Born in Bradford Study allows bone fide researchers to access data. Full details of how to do this are provided 
on the study web pages (https://borninbradford.nhs.uk/research/how-to-access-data/).
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